Dannette Doolittle

Director, Project and Portfolio Management at Vir Biotechnology, Inc.

Role
Director, Program and Portfolio Management at Vir Biotechnology, Inc.
Location
Houston, TX, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Dannette Doolittle

Played a pivotal role in driving an 18-month accelerated development timeline for sotrovimab (Xevudy), a monoclonal antibody for the treatment of COVID-19, to FDA Emergency Use Authorization in May 2021. Collaborated cross-functionally and with Vir’s global partner to achieve ~1.7 million doses sold worldwide and generating over $3 billion in revenue, with continued global impact through 2022. • Successful program and portfolio management experience; drug discovery to clinical study completion• Pharmaceutical drug development experience in large/small pharma, contract research and academic settings• Skilled user of Smartsheet, SharePoint, Microsoft Project, Word and Excel• Organized, multi-tasking, self-motivated and excellent communication skills

Experience

  1. Director, Program and Portfolio Management

    Vir Biotechnology, Inc.

    Mar 2025 — Present · Houston, TX, US

    Experienced leader supporting Vir\'s oncology and legacy infectious disease development programs+Pharmaceutical drug development experience in large/small pharma, contract research and academic settings+Skilled user of Smartsheet, Microsoft Project and other PM software programs+Organized, multi-tasking, self-motivated and excellent communication skills

Education

  • The University of Kansas

    Ph.D.

  • Nebraska Wesleyan University

    Bachelor of Science (B.S.)

Skills

  • Clinical Development
  • Lims
  • Pharmaceutics
  • Drug Discovery
  • Chromatography
  • Good Laboratory Practice (Glp)
  • Pharmaceutical Industry
  • Sop
  • Fda
  • Analytical Chemistry
  • Oncology
  • Gmp
  • Laboratory Information Management System (Lims)
  • Pharmacokinetics
  • Lc-Ms
  • Glp
  • Validation
  • Hplc
  • In Vivo
  • CRO
  • Standard Operating Procedure (Sop)
  • In Vitro
  • Drug Metabolism
  • Drug Development
  • Bioanalysis
  • Project Management

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Dannette Doolittle — Director, Program and Portfolio Management at Vir Biotechnology, Inc. in Houston, TX, US | Unifers